Synonym
L 654066; L-654066; L654066; MK 963; MK-963; MK963; MK0963; MK-0963; MK 0963;
IUPAC/Chemical Name
(5Alpha)-23-methyl-4-aza-21-norchol-1-ene-3,20-dione
InChi Key
RDPJISLOFXUIDK-RLAPWRJVSA-N
InChi Code
InChI=1S/C23H35NO2/c1-14(2)13-19(25)18-7-6-16-15-5-8-20-23(4,12-10-21(26)24-20)17(15)9-11-22(16,18)3/h10,12,14-18,20H,5-9,11,13H2,1-4H3,(H,24,26)/t15-,16-,17-,18+,20+,22-,23+/m0/s1
SMILES Code
CC(C)CC([C@H]1CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(C=C[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
357.54
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Olah TV, Gilbert JD, Barrish A, Greber TF, McLoughlin DA. A rapid and specific assay, based on liquid chromatography-atmospheric pressure chemical ionization mass spectrometry, for the determination of MK-434 (a 5 alpha- reductase inhibitor) and its metabolites in plasma. J Pharm Biomed Anal. 1994 May;12(5):705-12. doi: 10.1016/0731-7085(93)e0008-b. PMID: 7948192.
2: Schwartz JI, Laskin OL, Meeter CA, Patterson PM, Schneider SH, Lasseter KC, Seibold JR. Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrations. Clin Pharmacol Ther. 1994 Jan;55(1):50-4. doi: 10.1038/clpt.1994.9. PMID: 8299317.
3: Depré M, Meeter C, Van Hecken A, Laskin OL, Buntinx A, De Schepper PJ. Pharmacodynamics and tolerability of L-654,066, a steroid 5 alpha-reductase inhibitor, in men. Clin Pharmacol Ther. 1992 Oct;52(4):409-12. doi: 10.1038/clpt.1992.163. PMID: 1424413.
4: Gilbert JD, Olah TV, Barrish A, Greber TF. Determination of L-654,066, a new 5 alpha-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Biol Mass Spectrom. 1992 Jul;21(7):341-6. doi: 10.1002/bms.1200210704. PMID: 1420375.